BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3904070)

  • 21. Antidepressant treatment of bulimia: the relationship between bingeing and depressive symptomatology.
    Brotman AW; Herzog DB; Woods SW
    J Clin Psychiatry; 1984 Jan; 45(1):7-9. PubMed ID: 6582060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A placebo-controlled, double-blind trial of amitriptyline in bulimia.
    Mitchell JE; Groat R
    J Clin Psychopharmacol; 1984 Aug; 4(4):186-93. PubMed ID: 6381556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical depression.
    Silberman EK; Sullivan JL
    Psychiatr Clin North Am; 1984 Sep; 7(3):535-47. PubMed ID: 6384959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychological traits and platelet monoamine oxidase activity in eating disorder patients: their relationship and stability.
    Podar I; Jaanisk M; Allik J; Harro J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):248-53. PubMed ID: 16901600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A; McCue RE; Cooper TB; Nagachandran N; Friedhoff A
    Psychiatry Res; 1989 Apr; 28(1):1-9. PubMed ID: 2662234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of phenelzine and amitriptyline in depressed outpatients.
    Robinson DS; Nies A; Corcella J; Cooper TB; Spencer C; Keefover R
    J Clin Psychiatry; 1982 May; 43(5 Pt 2):8-15. PubMed ID: 7042699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defining the boundaries of atypical depression.
    Quitkin FM; Harrison W; Liebowitz M; McGrath P; Rabkin JG; Stewart J; Markowitz J
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bulimia with monoamine oxidase inhibitors.
    Walsh BT; Stewart JW; Wright L; Harrison W; Roose SP; Glassman AH
    Am J Psychiatry; 1982 Dec; 139(12):1629-30. PubMed ID: 6959533
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report.
    Herridge PL; Pope HG
    J Clin Psychopharmacol; 1985 Aug; 5(4):229-30. PubMed ID: 3926833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW; Harrison W; Cooper TB; Quitkin FM
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Activity of the enzymes participating in the metabolism of biogenic amines in patients with depressive syndromes. I. Platelet monoamine oxidase (MAO) activity].
    Matsumoto H; Pietruszewska I; Roguska E
    Psychiatr Pol; 1983; 17(1):7-11. PubMed ID: 6622594
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant.
    McGrath PJ; Stewart JW; Harrison W; Quitkin FM
    Psychopharmacol Bull; 1987; 23(1):169-72. PubMed ID: 3602314
    [No Abstract]   [Full Text] [Related]  

  • 36. Trazodone in the treatment of bulimia.
    Ware MR; Lydiard RB
    J Clin Psychopharmacol; 1986 Aug; 6(4):253-4. PubMed ID: 3461008
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alprazolam in the treatment of bulimia.
    Opler LA; Mickley D
    J Clin Psychiatry; 1986 Jan; 47(1):49. PubMed ID: 3455690
    [No Abstract]   [Full Text] [Related]  

  • 40. Mania associated with high percentage of inhibition of monoamine oxidase.
    Bowden CL; Seleshi E; Javors MA
    Am J Psychiatry; 1989 Jan; 146(1):121. PubMed ID: 2912232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.